OCompany · Healthtech & Bio
Omniscope
Omniscope is a TechBio company that combines high-resolution single-cell immune sequencing (T-cell/B-cell receptor repertoires) with AI to build an immune databank that maps 'immune age', tracks clonal dynamics and identifies cellular drivers of chronic disease and ageing. Its products include osLifetime, osLongevity, osSports and a clinical Immune Portal, aimed at immuno-oncology, longevity and sports performance. Founded in 2020 and headquartered in Barcelona with operations in Malta and a US entity in Delaware, it raised roughly $8M in a seed round announced in February 2025 and works with partners such as CNAG, Barça Innovation Hub, Fox Chase Cancer Center, GSK, Google Cloud and NVIDIA Inception.
Founded
2020
Founders
3
News
0
Rounds
1
Investors
5
SectorsHealthtech & Bio, AI & Data, Biotech, Immunology, Diagnostics, Longevity
Start-up MapHealthtech & Bio › Diagnostics & precision medicine testing
Profile updated 19 Aug 2026
Founders
H
Holger Heyn
Co-Founder & Chief Scientific Officer
L
Lynnette Ang
Co-Founder & Chief Growth Officer
—
V
Vijay Vaswani
Co-Founder & CEO
Global models
No comparables on record yet.
Investors 5
Funding rounds 1
News & media
No coverage on record yet.